Literature DB >> 3905113

The mast cell and bone.

M J McKenna, B Frame.   

Abstract

The mast cell, which contains many potent bioactive substances, by its very location must have an effect on bone metabolism in health and disease. In this article, the early questions about mast cells in bone raised by Urist and McLean almost thirty years ago are only partially answered, but the work continues to stimulate new experimental and clinical research on the function of mast cells.

Mesh:

Year:  1985        PMID: 3905113

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  14 in total

Review 1.  Advanced imaging of skeletal manifestations of systemic mastocytosis.

Authors:  J Fritz; E K Fishman; J A Carrino; M S Horger
Journal:  Skeletal Radiol       Date:  2012-02-26       Impact factor: 2.199

2.  Localised mastocytosis at the bone and porous coated interface of a knee prosthesis.

Authors:  O Delaere; J Delaere; A Dhem
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

3.  Increased bone fracture prevalence in postmenopausal women suffering from pollen-allergy.

Authors:  Viktoria Ferencz; Szilvia Meszaros; Emoke Csupor; Edit Toth; Katalin Bors; Andras Falus; Csaba Horvath
Journal:  Osteoporos Int       Date:  2006-01-24       Impact factor: 4.507

4.  Effect of heparin on bone formation in cultured fetal rat calvaria.

Authors:  M M Hurley; G Gronowicz; B E Kream; L G Raisz
Journal:  Calcif Tissue Int       Date:  1990-03       Impact factor: 4.333

5.  Histomorphometric study of mast cells in normal bone, osteoporosis and mastocytosis using a new stain.

Authors:  M J McKenna
Journal:  Calcif Tissue Int       Date:  1994-10       Impact factor: 4.333

6.  Osteoblast-like cell line maintains in vitro rat peritoneal mast cell viability and functional activity.

Authors:  F Levi-Schaffer; Z Bar-Shavit
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

7.  Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis.

Authors:  S Seitz; F Barvencik; T Koehne; M Priemel; P Pogoda; J Semler; H Minne; M Pfeiffer; J Zustin; K Püschel; C Eulenburg; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2013-02-23       Impact factor: 4.507

8.  Presence of tumour necrosis factor or a related factor in human basophil/mast cells.

Authors:  M Steffen; M Abboud; G K Potter; Y P Yung; M A Moore
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

Review 9.  The osteoporosis of heparinotherapy and systemic mastocytosis.

Authors:  T Bardin; M Lequesne
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

10.  Partial inhibition of bone resorption by disodium cromoglycate in a synchronized model of bone remodeling.

Authors:  C Dobigny; J L Saffar
Journal:  Agents Actions       Date:  1991-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.